Literature DB >> 11246163

Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization.

H Y Yang1, S Wilkening, M J Iadarola.   

Abstract

Persistent nociceptive input increases neuronal excitability and induces a program of gene expression in the dorsal spinal cord. The alteration in gene expression commences with phosphorylation and induction of immediate early genes and proceeds to target genes. Only a few target genes have been identified as yet. The present report uses a polymerase chain reaction-based subtraction cloning procedure to obtain an "anatomically focused" complementary DNA library enriched in transcripts related to sensory spinal cord (rat dorsal horn minus ventral horn). A subset of clones from this library (n=158) was screened to verify dorsal horn enrichment and to identify those regulated by carrageenan-induced peripheral inflammation. Molecular classes which displayed enriched expression included a proto-oncogene not previously associated with sensory processes, two regulators of the Rho/Rac pathway which controls cell shape, and three genes involved in cytoskeletal regulation and scaffolding. Additional transcripts coded for proteins involved in intercellular communication or intracellular function. Within the set of 158 transcripts, one known and two unknown genes were induced by persistent noxious input. The known gene codes for the secreted cysteine proteinase inhibitor, cystatin C, suggesting that modulation of extracellular proteolytic activity occurs. Since it is secreted, cystatin C may also provide a cerebrospinal fluid bio-marker for persistent pain states. Using a combined anatomical and functional approach, we have extended the molecular repertoire of genes expressed and induced in second-order neurons or supporting glial cells in several new directions, with particular emphasis on regulation of cell morphology and plasma membrane dynamics. Some of these proteins reveal new pathways for information signaling in the sensory half of the spinal cord and require further research to understand their role in the adult spinal cord. The induced genes may provide new molecular targets for therapeutic development and provide new probes for investigating the dynamic state of cellular activity that occurs during persistent pain states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246163     DOI: 10.1016/s0306-4522(00)00573-x

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  RT-PCR analysis of pain genes: use of gel-based RT-PCR for studying induced and tissue-enriched gene expression.

Authors:  Kendall Mitchell; Michael J Iadarola
Journal:  Methods Mol Biol       Date:  2010

Review 2.  The vanilloid agonist resiniferatoxin for interventional-based pain control.

Authors:  Michael J Iadarola; Andrew J Mannes
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 3.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

4.  Molecular signatures of mouse TRPV1-lineage neurons revealed by RNA-Seq transcriptome analysis.

Authors:  Samridhi C Goswami; Santosh K Mishra; Dragan Maric; Krisztian Kaszas; Gian Luigi Gonnella; Samuel J Clokie; Hal D Kominsky; Jacklyn R Gross; Jason M Keller; Andrew J Mannes; Mark A Hoon; Michael J Iadarola
Journal:  J Pain       Date:  2014-10-02       Impact factor: 5.820

Review 5.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

6.  Cystatin C in Alzheimer's disease.

Authors:  Gurjinder Kaur; Efrat Levy
Journal:  Front Mol Neurosci       Date:  2012-07-06       Impact factor: 5.639

7.  Differential expression of Cathepsin S and X in the spinal cord of a rat neuropathic pain model.

Authors:  Anna Leichsenring; Ingo Bäcker; Wiebke Wendt; Michael Andriske; Beate Schmitz; Christine C Stichel; Hermann Lübbert
Journal:  BMC Neurosci       Date:  2008-08-12       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.